XW013G6 Introduction of REGN-COV2 Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
Section: New Technology
Body system: Anatomical Regions
Operation: Introduction — Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products